Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAGBiotechnology
+$2.32 today
- Market cap
- $1.83B
- Beta
- 0.00
Volume 0.30M
Average 0.34M
COAG Account Payables
Amounts the company owes suppliers for goods and services received.
Hemab Therapeutics Holdings, Inc. Common StockNASDAQ: COAG
Account Payables · Q2 FY2026 · quarter ended Jun 2026
Account payables of $6.23M in Q2 FY2026
Q2 FY2026 account payables was $6.23M.
Context
- Account payables amounted to 1.3% of total assets at the end of Q2 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 5.73M USD
- Year-over-year change
- —
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.73M | — |
Account Payables vs competitors
How COAG compares with its peers on the latest reported figures
- COAG's Jun 2026 account payables of $6.23M is the highest of the 5 companies compared; the peer median is $2.67M.
- Account payables amounts to 1.3% of total assets for COAG, versus a peer median of 0.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
COAGHemab Therapeutics Holdings, Inc. Common Stock | Jun 2026 | $6.23M | — | — | 1.3% |
IRONDisc Medicine, Inc. | Sep 2026 | $6.07M | -16.4% | -17.7% | 0.9% |
| Mar 2026 | $4.4M | -16.5% | -22.2% | 0.6% | |
| Mar 2026 | $940K | +135.0% | -51.6% | 1.7% | |
DMRADamora Therapeutics, Inc. | Mar 2026 | $819K | +131.4% | -49.0% | 0.2% |
| Peer median (excluding COAG) | $2.67M | +57.5% | -35.6% | 0.7% | |
Competitors are the stored peer set for COAG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG
Intrinsic Alpha fair value
Locked
Current Price
$39.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.